149.45
price down icon0.53%   -0.80
pre-market  プレマーケット:  150.45   1.00   +0.67%
loading
前日終値:
$150.25
開ける:
$150.13
24時間の取引高:
1.28M
Relative Volume:
1.45
時価総額:
$7.36B
収益:
$4.06B
当期純損益:
$413.08M
株価収益率:
18.66
EPS:
8.01
ネットキャッシュフロー:
$560.48M
1週間 パフォーマンス:
-2.14%
1か月 パフォーマンス:
-7.66%
6か月 パフォーマンス:
-10.50%
1年 パフォーマンス:
-25.51%
1日の値動き範囲:
Value
$147.46
$150.87
1週間の範囲:
Value
$147.46
$157.95
52週間の値動き範囲:
Value
$91.86
$230.02

Charles River Laboratories International Inc Stock (CRL) Company Profile

Name
名前
Charles River Laboratories International Inc
Name
セクター
Healthcare (1150)
Name
電話
781-222-6000
Name
住所
251 BALLARDVALE ST, WILMINGTON, MA
Name
職員
20,100
Name
Twitter
@criverlabs
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
CRL's Discussions on Twitter

CRL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Diagnostics & Research icon
CRL
Charles River Laboratories International Inc
149.45 7.39B 4.06B 413.08M 560.48M 8.01
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
468.00 177.38B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
185.91 135.85B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
627.17 51.87B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
124.38 35.70B 6.79B 1.22B 1.09B 4.26
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
181.24 31.70B 15.70B 1.24B 2.01B 6.91

Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-09 アップグレード Jefferies Hold → Buy
2025-07-09 アップグレード Citigroup Neutral → Buy
2025-05-23 アップグレード Redburn Atlantic Neutral → Buy
2025-05-14 アップグレード TD Cowen Hold → Buy
2025-05-08 アップグレード Evercore ISI In-line → Outperform
2025-03-21 ダウングレード Goldman Buy → Neutral
2025-03-04 アップグレード Citigroup Sell → Neutral
2025-03-03 アップグレード Redburn Atlantic Sell → Neutral
2025-01-22 ダウングレード William Blair Outperform → Mkt Perform
2025-01-17 ダウングレード UBS Buy → Neutral
2024-11-18 ダウングレード CLSA Hold → Underperform
2024-11-07 アップグレード CLSA Underperform → Hold
2024-10-23 開始されました CLSA Underperform
2024-10-14 開始されました Redburn Atlantic Sell
2024-10-07 ダウングレード Evercore ISI Outperform → In-line
2024-10-02 ダウングレード BofA Securities Buy → Neutral
2024-10-01 ダウングレード Citigroup Neutral → Sell
2024-08-08 ダウングレード JP Morgan Overweight → Neutral
2024-08-08 ダウングレード Robert W. Baird Outperform → Neutral
2024-06-28 ダウングレード Argus Buy → Hold
2024-06-07 開始されました Mizuho Neutral
2024-06-06 開始されました Goldman Buy
2024-02-15 ダウングレード Guggenheim Buy → Neutral
2023-09-13 開始されました TD Cowen Market Perform
2023-07-10 ダウングレード Citigroup Buy → Neutral
2023-02-23 アップグレード Guggenheim Neutral → Buy
2023-01-12 ダウングレード Jefferies Buy → Hold
2022-09-30 アップグレード Jefferies Hold → Buy
2022-08-25 開始されました Credit Suisse Outperform
2022-08-04 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-05-24 開始されました Guggenheim Neutral
2022-04-25 ダウングレード Jefferies Buy → Hold
2022-04-07 開始されました Stephens Overweight
2022-02-17 繰り返されました BofA Securities Buy
2022-02-17 アップグレード Citigroup Neutral → Buy
2022-02-17 繰り返されました Deutsche Bank Buy
2022-02-17 繰り返されました Morgan Stanley Overweight
2022-02-17 繰り返されました UBS Buy
2021-08-05 再開されました Credit Suisse Neutral
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-09-10 アップグレード Jefferies Hold → Buy
2020-07-01 アップグレード BofA Securities Neutral → Buy
2020-05-13 アップグレード UBS Neutral → Buy
2020-04-21 ダウングレード Jefferies Buy → Hold
2020-03-27 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-03-02 開始されました Deutsche Bank Buy
2020-02-18 アップグレード Wolfe Research Peer Perform → Outperform
2020-01-10 アップグレード Goldman Neutral → Buy
2020-01-08 開始されました Wells Fargo Overweight
2020-01-07 開始されました Citigroup Buy
2019-10-18 ダウングレード BofA/Merrill Buy → Neutral
2019-06-10 開始されました SVB Leerink Outperform
2019-04-30 再開されました Evercore ISI Outperform
2018-12-14 開始されました Deutsche Bank Buy
2018-10-09 開始されました UBS Neutral
2018-08-23 アップグレード Raymond James Mkt Perform → Outperform
2018-07-17 アップグレード RBC Capital Mkts Sector Perform → Outperform
2018-06-15 アップグレード KeyBanc Capital Mkts Sector Weight → Overweight
2018-02-14 アップグレード SunTrust Hold → Buy
すべてを表示

Charles River Laboratories International Inc (CRL) 最新ニュース

pulisher
Sep 24, 2025

Assenagon Asset Management S.A. Acquires 11,408 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Pharmaceutical Contract Research Services Market Report 2025-2035: M&A, Partnerships, and Biologics Focus - GlobeNewswire Inc.

Sep 24, 2025
pulisher
Sep 24, 2025

Is Charles River Laboratories Stock Underperforming The Nasdaq? - Barchart.com

Sep 24, 2025
pulisher
Sep 23, 2025

Research Analysts Issue Forecasts for CRL Q3 Earnings - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Charles River Laboratories International (NYSE:CRL) Rating Lowered to "Buy" at Wall Street Zen - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Charles River Laboratories (CRL): Valuation Perspectives After CFO Transition, Guidance Reaffirmation, and New Oncology Partnerships - simplywall.st

Sep 23, 2025
pulisher
Sep 23, 2025

Brokerages Set Charles River Laboratories International, Inc. (NYSE:CRL) Price Target at $177.07 - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Mice Model Market to Reach US$ 3.60 Bn by 2032, Expanding at 9.9% CAGRCoherent Market Insights | Charles River Laboratories, The Jackson Laboratory - industrytoday.co.uk

Sep 23, 2025
pulisher
Sep 22, 2025

Charles River Laboratories International, Inc. $CRL Stock Position Lifted by Balefire LLC - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Fragasso Financial Advisors Inc Sells 2,140 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat

Sep 22, 2025
pulisher
Sep 21, 2025

How Charles River Laboratories’ CFO Transition and Maintained Outlook May Shift Its Investment Story (CRL) - simplywall.st

Sep 21, 2025
pulisher
Sep 20, 2025

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Sells 51,622 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

Signal Recap: Will ERIE stock hit new highs in YEARQuarterly Portfolio Report & AI Enhanced Market Trend Forecasts - khodrobank.com

Sep 20, 2025
pulisher
Sep 19, 2025

Sell Signal: Is Charles River Laboratories International Inc in accumulation or distribution phaseRecession Risk & Real-Time Volume Analysis - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Argus Research Remains a Hold on Charles River Labs (CRL) - The Globe and Mail

Sep 19, 2025
pulisher
Sep 19, 2025

Tech Rally: Will Charles River Laboratories International Inc. benefit from green energy policiesBuy Signal & Comprehensive Market Scan Reports - خودرو بانک

Sep 19, 2025
pulisher
Sep 18, 2025

Market Recap: What are the future prospects of Charles River Laboratories International IncRate Cut & Precise Swing Trade Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Volume Report: What are the future prospects of Charles River Laboratories International IncPortfolio Return Report & Precise Swing Trade Entry Alerts - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Charles River Laboratories International (NYSE:CRL) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat

Sep 18, 2025
pulisher
Sep 17, 2025

CEO Moves: Will Charles River Laboratories International Inc. outperform tech stocks2025 Fundamental Recap & Growth Focused Stock Reports - khodrobank.com

Sep 17, 2025
pulisher
Sep 17, 2025

MBB Public Markets I LLC Purchases New Position in Charles River Laboratories International, Inc. $CRL - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

Here’s Why ClearBridge Investments Growth Strategy Closed Out Charles River Laboratories International (CRL) - Yahoo

Sep 17, 2025
pulisher
Sep 17, 2025

Value Recap: What is Immuneering Corporation s debt to equity ratioJuly 2025 Patterns & Reliable Intraday Trade Alerts - khodrobank.com

Sep 17, 2025
pulisher
Sep 17, 2025

Amundi Sells 53,919 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

Goldman Sachs Group Inc. Purchases 800,762 Shares of Charles River Laboratories International, Inc. $CRL - MarketBeat

Sep 17, 2025
pulisher
Sep 17, 2025

Institution Moves: Is Ovid Therapeutics Inc. a good ESG investment2025 Risk Factors & Fast Entry Momentum Trade Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

Charles River Laboratories Announces Chief Financial Officer Transition - BioSpace

Sep 17, 2025
pulisher
Sep 16, 2025

Medical device maker Insulet taps industry veteran Flavia Pease as CFO - Reuters

Sep 16, 2025
pulisher
Sep 16, 2025

Quarterly Trades: What is the long term forecast for Charles River Laboratories International Inc. stockWeekly Market Summary & Pattern Based Trade Signal System - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Charles River Laboratories Appoints Michael G. Knell as Interim CFO - citybiz.co

Sep 16, 2025
pulisher
Sep 16, 2025

Revenue Check: Will BLFS be affected by tariffsMarket Sentiment Review & Stepwise Trade Signal Implementation - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Charles River Labs CFO takes job at local medical device giant - The Business Journals

Sep 16, 2025
pulisher
Sep 16, 2025

Charles River Laboratories International, Inc. Announces Resignation of Flavia H. Pease, Corporate Executive Vice President from Her Role, Effective September 29, 2025 - MarketScreener

Sep 16, 2025
pulisher
Sep 16, 2025

Charles River Laboratories International, Inc. Announces Chief Financial Officer Transition - MarketScreener

Sep 16, 2025
pulisher
Sep 16, 2025

Charles River Laboratories (CRL) Appoints Interim CFO Amid Leade - GuruFocus

Sep 16, 2025
pulisher
Sep 16, 2025

Charles River Laboratories (CRL) Maintains FY25 Revenue Forecast - GuruFocus

Sep 16, 2025
pulisher
Sep 16, 2025

Charles River (CRL) Executive Moves to Insulet as CFO - GuruFocus

Sep 16, 2025
pulisher
Sep 16, 2025

Jobs Data: Is Charles River Laboratories International Inc. in a long term uptrend2025 Stock Rankings & Precise Swing Trade Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Charles River Laboratories International, Inc. Reaffirms Earnings Guidance for Year 2025 - MarketScreener

Sep 16, 2025
pulisher
Sep 16, 2025

Logan Capital Management Inc. Has $1.74 Million Stake in Charles River Laboratories International, Inc. $CRL - MarketBeat

Sep 16, 2025
pulisher
Sep 15, 2025

Aug Fed Impact: Whats next for Charles River Laboratories International Inc stock2025 Historical Comparison & Proven Capital Preservation Tips - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Insider Sell: Is Charles River Laboratories International Inc. forming a breakout pattern2025 Biggest Moves & Community Shared Stock Ideas - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Baird Adjusts PT on Charles River Laboratories International to $161 From $151, Maintains Neutral Rating - MarketScreener

Sep 15, 2025
pulisher
Sep 15, 2025

Can Schneider National Inc scale operations efficiently2025 Stock Rankings & Advanced Swing Trade Entry Plans - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Travel Stocks: Why is Charles River Laboratories International Inc. stock going upWeekly Earnings Recap & Real-Time Buy Signal Notifications - خودرو بانک

Sep 15, 2025
pulisher
Sep 14, 2025

Charles River Laboratories International (NYSE:CRL) Shares Gap UpHere's What Happened - MarketBeat

Sep 14, 2025

Charles River Laboratories International Inc (CRL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
diagnostics_research WAT
$292.65
price down icon 2.20%
diagnostics_research DGX
$186.82
price down icon 0.08%
$163.91
price down icon 5.16%
diagnostics_research LH
$279.35
price down icon 0.21%
diagnostics_research MTD
$1,242.28
price down icon 1.17%
diagnostics_research IQV
$181.24
price down icon 2.79%
大文字化:     |  ボリューム (24 時間):